Detection of Dengue Virus in Plasma of Patients in Nepal

Status Completed

Clinical Trial Summary

To test whether Karius Infectious Disease Diagnostic Sequencing assay can detect Dengue Virus in plasma from suspected cases of Dengue or Dengue Fever like-illnesses from samples collected as part of a hospital-based multi-site study conducted in Nepal.

Clinical Trial Description

Blood samples will be obtained from consented subjects as part of a hospital-based multi-site study conducted in Nepal and will be shipped to Karius, Redwood City, CA. The investigators will test whether the Karius test can detect Dengue Virus in plasma from those suspected cases and measure the performance of the Karius test against standard tests (PCR, ELISA test and neutralization assays) used to determine a final diagnosis of Dengue Fever. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03620487
Study type	Observational
Source	Karius, Inc.
Contact
Status	Completed
Phase
Start date	October 26, 2016
Completion date	July 31, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04514107` - A Cluster-randomized Trial to EValuate the Efficacy of Wolbachia-InfecTed Aedes Aegypti Mosquitoes in Reducing the Incidence of Arboviral Infection in Brazil (EVITA Dengue)	Phase 2
Completed	`NCT00788151` - Study of ChimeriVax™ Tetravalent Dengue Vaccine in Healthy Peruvian Children Aged 2 to 11 Years	Phase 2
Completed	`NCT02510638` - The Clinical Epidemiology of Hospitalized Dengue Cases in Malaysia	N/A
Completed	`NCT01666652` - A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults	Phase 1
Completed	`NCT01477671` - Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children	N/A
Completed	`NCT01443247` - Role of Andi-d in Dengue Fever: a Pilot Study	N/A
Completed	`NCT00831012` - Safety of and Immune Response to a Dengue Virus Vaccine (rDEN3delta30/31‐7164) in Healthy Adults	Phase 1
Completed	`NCT00089908` - Safety of and Immune Response to a Dengue Virus Vaccine (rDEN1delta30) in Healthy Adults	Phase 1
Completed	`NCT01983553` - Long-Term Study of Hospitalized Dengue & Safety in Thai Children Included in a Tetravalent Dengue Vaccine Efficacy Study
Completed	`NCT01134263` - Study of a Tetravalent Dengue Vaccine in Healthy Adults in Australia	Phase 3
Completed	`NCT02741128` - Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults	Phase 2
Recruiting	`NCT02608047` - Studies on the Pathogen, Vector Control and Clinical Treatment of Dengue Fever in Guangzhou	N/A
Completed	`NCT02510690` - Factors Associated With Poor Dengue Outcomes in Malaysia	N/A
Completed	`NCT01550016` - International Research Consortium on Dengue Risk Assessment, Management, and Surveillance	N/A
Completed	`NCT01421732` - Laboratory Diagnosis and Prognosis of Severe Dengue	N/A
Completed	`NCT00993447` - Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America	Phase 2
Completed	`NCT01224639` - Safety and Immunogenicity Study to Assess TDV, a Live Attenuated Tetravalent Vaccine for Prevention of Dengue Fever	Phase 1
Completed	`NCT01943825` - Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine	Phase 2
Active, not recruiting	`NCT03465254` - Dengue Serostatus Study in the Philippines
Completed	`NCT01702857` - A Two-dose Primary Vaccination Study of a Tetravalent Dengue Virus Purified Inactivated Vaccine vs. Placebo in Healthy Adults (in Puerto Rico)	Phase 1